Literature DB >> 6511549

Near-maximal voluntary hyperpnea and ventilatory muscle function.

T R Bai, B J Rabinovitch, R L Pardy.   

Abstract

Because of its potential relevance to heavy exercise we studied the ventilatory muscle function of five normal subjects before, during, and after shortterm near-maximal voluntary normocapnic hyperpnea. Measurements of pleural and abdominal pressures and diaphragm electromyogram (EMG) during hyperpnea and of maximum respiratory pressures before and after hyperpnea were made at four levels of ventilation: 76, 79, and 86% maximal voluntary ventilation (MVV) and at MVV. Measurements of pleural and abdominal pressures and diaphragm electromyogram (EMG) during hyperpnea and of maximum respiratory pressures before and after hyperpnea were made. The pressure-stimulation frequency relationship of the diaphragm obtained by unilateral transcutaneous phrenic nerve stimulation was studied in two subjects before and after hyperpnea. Decreases in maximal inspiratory (PImax) and transdiaphragmatic (Pdimax) strength were recorded posthyperpnea at 76 and 79% MVV. Decreases in the pressure-frequency curves of the diaphragm and the ratio of high-to-low frequency power of the diaphragm EMG occurred in association with decreases in Pdimax. Analysis of the pressure-time product (P X dt) for the inspiratory and expiratory muscles individually indicated the increasing contribution of expiratory muscle force to the attainment of higher levels of ventilation. Demonstrable ventilatory muscle fatigue may limit endurance at high levels of ventilation.

Entities:  

Mesh:

Year:  1984        PMID: 6511549     DOI: 10.1152/jappl.1984.57.6.1742

Source DB:  PubMed          Journal:  J Appl Physiol Respir Environ Exerc Physiol        ISSN: 0161-7567


  13 in total

Review 1.  Athletes and doping: effects of drugs on the respiratory system.

Authors:  P N Dekhuijzen; H A Machiels; L M Heunks; H F van der Heijden; R H van Balkom
Journal:  Thorax       Date:  1999-11       Impact factor: 9.139

2.  Influence of isocapnic hyperpnoea on maximal arm cranking performance.

Authors:  Siska Van Houtte; J Verellen; R Gosselink; Y C Vanlandewijck
Journal:  Eur J Appl Physiol       Date:  2003-08-16       Impact factor: 3.078

3.  Effect of maximum ventilation on abdominal muscle relaxation rate.

Authors:  D Kyroussis; G H Mills; M I Polkey; C H Hamnegard; S Wragg; J Road; M Green; J Moxham
Journal:  Thorax       Date:  1996-05       Impact factor: 9.139

4.  Runners maintain locomotor-respiratory coupling following isocapnic voluntary hyperpnea to task failure.

Authors:  Abigail S L Stickford; Jonathon L Stickford; David A Tanner; Joel M Stager; Robert F Chapman
Journal:  Eur J Appl Physiol       Date:  2015-07-22       Impact factor: 3.078

Review 5.  Clinical management of chronic obstructive pulmonary disease patients with muscle dysfunction.

Authors:  Joaquim Gea; Carme Casadevall; Sergi Pascual; Mauricio Orozco-Levi; Esther Barreiro
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

Review 6.  Pulmonary rehabilitation in chronic respiratory insufficiency. 3. Ventilatory muscle training.

Authors:  R S Goldstein
Journal:  Thorax       Date:  1993-10       Impact factor: 9.139

7.  Respiratory muscle function in trained and untrained adolescents during short-term high intensity exercise.

Authors:  M L Choukroun; C Kays; M Gioux; P Techoueyres; H Guenard
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1993

8.  Inspiratory muscle endurance in patients with chronic heart failure.

Authors:  J T Walsh; R Andrews; P Johnson; L Phillips; A J Cowley; W J Kinnear
Journal:  Heart       Date:  1996-10       Impact factor: 5.994

9.  A non-invasive method for measuring inspiratory muscle fatigue during progressive isocapnic hyperventilation in man.

Authors:  D Vilozni; E Bar-Yishay; C S Beardsmore; M Shochina; E Wolf; S Godfrey
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1987

10.  Exercise-induced diaphragmatic fatigue in healthy humans.

Authors:  B D Johnson; M A Babcock; O E Suman; J A Dempsey
Journal:  J Physiol       Date:  1993-01       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.